CYP1A2 and ovarian carcinoma: According to the study of Goodman and coworkers, ovarian cancer risk may be modified by CYP1A2 genotype (higher risk among women with the A/A genotype than among women with the C allele) and other factors that influence CYP1A2 expression [108].